Log in to save to my catalogue

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1889385514

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

About this item

Full title

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

Publisher

London: Springer London

Journal title

International Urogynecology Journal, 2017-11, Vol.28 (11), p.1657-1661

Language

English

Formats

Publication information

Publisher

London: Springer London

More information

Scope and Contents

Contents

Introduction and hypothesis
Mixed urinary incontinence (MUI), defined as mixed symptoms of stress urinary incontinence (SUI) and overactive bladder (OAB), is a difficult entity if conservative treatment has failed. Cure rates are low compared with SUI, particularly the OAB component, may deteriorate after sling insertion. Bulking agents pose an...

Alternative Titles

Full title

Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1889385514

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1889385514

Other Identifiers

ISSN

0937-3462

E-ISSN

1433-3023

DOI

10.1007/s00192-017-3332-5

How to access this item